Your missing links are here (28 October 2019)
By: Rasmus Kragh Jakobsen - Oct. 28, 2019
CMN Intelligence - The World’s Most Comprehensive Intelligence Platform for CRISPR-Genomic Medicine and Gene-Editing Clinical Development
Providing market intelligence, data infrastructure, analytics, and reporting services for the global gene-editing sector. Read more...
Top picks
- The new Prime Editing prototype gene editing method explained by Emma Yasinski at The Scientist. Combining CRISPR-Cas9 and base-editing David Liu and colleagues at the Broad Institute cuts only one strand of DNA to gain better precision and similar efficiency as CRISPR-Cas9 solo. Also here and here.
- Russian ‘CRISPR-baby’ scientist has started work. David Cyranoski, Nature News, reports that biologist Denis Rebrikov's controversial 'CRISPR-baby' plans have taken a turn from making HIV resistant babies to repair the gene linked to deafness, called GJB2. And here. And meet a deaf woman who considers collaborating with Rebrikov to have hearing 'CRISPR-babies'.
- Promising new gene therapy for Duchenne muscular dystrophy using dystrophin's distant cousin utrophin
- Geneticists retract study suggesting the chinese 'CRISPR-babies' might die early
- Dynamic genomes - feature on how genes are born de novo from barren stretches of the genome.
Visionaries
- Bill Gates og NIH invests in CRISPR gene therapy for the poor
- NIH director, Francis S. Collins, lays out inspirational vision for the future of medical science
- Jennifer Doudna on the gene-editing revolution
Industry
- Bluebird Bio gets green light from European health regulators for manufacturing blood disease gene therapy
- 100 infants treated for spinal muscular atrophy with first commercialised gene therapy
- Novo Nordisk enters haemophilia gene therapy collaboration with Bluebird Bio
Uh ah wow
- Amazing scientific visualization - 3D digital video tour for learning about biology and medicine
- More visuals - I just love Nikon’s Small World Competition 'showcasing the beauty and complexity of life as seen through the light microscope'. Image Credit: Teresa Zgoda & Teresa Kugler, winning entry Nikon Small World Competition 2019
- Oh, finally there's the tiny Greta beetle, and the rat-mobile (VIDEO)
Tags
CLINICAL TRIALS
IND Enabling
Phase I
Phase II
Phase III
Gastric Cancer and Colorectal Cancer, CRC, (NCT07166263)
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory Acute Myeloid Leukemia, AML, (NCT06541444)
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.
IND Enabling
Phase I
Phase II
Phase III







